Qi Gong as a Method of Craving Reduction in Severe Addict Patients

NCT ID: NCT03589118

Last Updated: 2019-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

186 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-04

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Craving arises in response to an affective tone that is associated with perceptual representations of a sensory object, rather than directly in response to the object.

The investigators presume that qi gong functions to decouple pleasant and unpleasant experience from habitual reactions by removing the affective bias that fuels such emotional reactivity. Qi gong training may specifically target the associated learning process with an emphasis on the critical link between affect and craving in an addictive loop.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The treatment of severe addiction to alcohol and one other or more psychoactive substances sometimes requires hospitalization for complex withdrawal. The medical term " sevrage complexe " is used in this file for hospitalization of patients with multiple addictions or with multiple comorbidities. In the french regulation the duration of hospitalization for " sevrage complexe " is at least 13 days.

The acute period of the first week is sufficient for physical weaning. A period relay for maintaining abstinence beyond the acute phase is a difficult stage. During this period the psychological craving related to the absence of the product causes dysphoria, stress, emotivity and increased difficulty in managing psychological aggression. The risk of relapse is then maximal and favored by many insults of everyday life.

Qi gong is classified by US National Library of Medicine as a mind-body therapy (MBT). It's an ancient traditional Chinese health practice believed to have special healing and recovery power. Today millions of people practice qi gong in China and around the world to treat various diseases. Qi gong is an ecole of breath, relaxation, guided imagery and inward attention. Practice of qi gong is believed to help cleanse the body of toxins, restore energy balance, reduce stress and anxiety. The Baduanjin qigong is one of the most common form of Chinese qi gong.

When going through withdrawal, craving is a psychological urge to administer a discontinued medication or recreational drug. Craving episodes may be triggered by seeing objects or experiencing moments that are associated with the drug or usage of it, and this phenomenon is termed post-acute withdrawal syndrome.

The main goal of our study is to demonstrate a reduction of craving during alcohol and coaddictions withdrawal. This demonstration is of first importance: first for the well-being of the patient during the first weeks after withdrawal, second for drug savings, and third abstinence rate because many authors consider that craving intensity is correlated with relapses risk.

The mind-body techniques of traditional Chinese medicine, as Qigong, are inscribed the number of current approaches in residential treatment. Their transmission would be an additional contribution to the stabilization via active management and motivated patient himself on his health.

The compulsion associated with addictive behavior can be defined as a pathological change in brain plasticity. The pathological learning process induced by the repeated use of the substance is causing behavioral control loss in the vulnerable individual.

Considering the impulsive nature of craving, this study will investigate the driving dynamics of impulses: Trieb "push". Return to the perception supported by the development of attention gestures leaning on the breath, puts us ahead of the motor action and is potentially a mean of influencing compulsive process.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Addiction Alcohol Dependence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients are randomized in two groups :

* usual medical and psychological support in the control group
* qi gong sessions added in the experimental group

Allocation between groups qi and control is 1 : 1
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Primary outcome (VAS scale) will be presented to the patient and reported by a study nurse blinded of the randomization arm of the patient.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Qi Gong

Qi gong sessions added to usual well defined medical and psychological support

Group Type EXPERIMENTAL

Qi Gong sessions

Intervention Type OTHER

13 sessions of Qi Gong in a 9 weeks period

Control

Usual well defined medical and psychological support

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Qi Gong sessions

13 sessions of Qi Gong in a 9 weeks period

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meets DSM 5 criteria for alcohol use disorder and other substance use disorders
* Alcohol is one of the major abused substances if using multiple substances
* Severity of the disorder defines by the necessity of a complex withdrawal hospitalization.
* Used alcohol in the 3 weeks before hospitalization
* Seeks addiction treatment
* Patient willing to adhere to the study protocol (e.g. attend all visits and follow-ups in the next 3 months).
* Age ≥ 18
* Negative pregnancy test (βHCG) for women of child bearing potential
* Signed informed consent
* Affiliation to the French health insurance (recipient or assign)
* Oral and written comprehension of the french langage


* Pose a current suicidal risk including active suicidal ideation and suicide attempt in the past 30 days
* Non stabilized severe psychiatric comorbidities such as bipolar disorder, schizophrenia, … (at the investigator's discretion)
* Pregnant or breastfeeding women
* Decompensated cirrhosis, liver encephalopathy, neurological complications, severe cognitive impairment and any other severe somatic comorbidity (at the investigator's discretion)
* Currently participated in other interventional clinical study
* Individuals placed under guardianship
* Patient deprived of freedom
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alain BAUMELOU, MD, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Nathalie PLET, Ph.D

Role: STUDY_DIRECTOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Saint ELOI

Montpellier, , France

Site Status RECRUITING

Hôpital L'ARCHET

Nice, , France

Site Status ACTIVE_NOT_RECRUITING

Groupe Hospitalier Pitié Salpêtrière

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alain BAUMELOU, MD, Ph.D

Role: CONTACT

01 42 16 05 75 ext. 0033

Nathalie PLET, Ph.D

Role: CONTACT

01 42 16 05 75 ext. 0033

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hélène DONNADIEU-RIGOLE, MD, PHD

Role: primary

0467337020 ext. 0033

Bruno MILLET, MD, PHD

Role: primary

0142162894 ext. 0033

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A02986-47

Identifier Type: REGISTRY

Identifier Source: secondary_id

P160946J

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.